Related Experiment Video
Updated: Oct 14, 2025

Formation of Dispersible Taohong Siwu Tablets
Published on: February 3, 2023
Mucoadhesive buccal tablets with propranolol hydrochloride: Formulation development and in vivo performances in
Ivana Kurćubić1, Una-Jovana Vajić2, Sandra Cvijić1
1Department of Pharmaceutical Technology and Cosmetology, Faculty of Pharmacy, University of Belgrade, Vojvode Stepe 450, 11221 Belgrade, Serbia.
Abstract:
The objective of this study was to formulate extended-release mucoadhesive buccal tablets of propranolol hydrochloride in order to provide a prolonged absorption of propranolol hydrochloride from the buccal mucosa and to reduce presystemic metabolism and thus provide a better therapeutic effect. Besides, the aim was to perform comparative in vivo pharmacokinetic and hemodynamic studies of the developed extended-release (ER) propranolol hydrochloride 10 mg mucoadhesive buccal tablets and commercial immediate-release (IR) propranolol hydrochloride 10 mg tablets in spontaneously hypertensive rats. Formulation with 15% polyethylene oxide showed the highest degree of propranolol hydrochloride permeation, satisfactory mucoadhesiveness, and extended-release of propranolol hydrochloride, thus it was selected for further in vivo study. The pharmacokinetic study in rats showed the superiority of ER mucoadhesive buccal tablets over IR tablets in terms of propranolol hydrochloride absorption extent (AUC values: 70.32 ± 19.56 versus 31.69 ± 6.97 µg·h/mL), although lower maximum plasma propranolol hydrochloride concentration (Cmax) was achieved. However, no statistically significant difference was observed in Cmax between these treatments. The hemodynamic study showed that ER mucoadhesive buccal tablets provide a more pronounced decrease primarily in heart rate, but also in systolic and diastolic arterial pressure, as well as a longer heart rate reduction compared to IR tablets.
Related Concept Videos
Drug Delivery: Enteral Route
Antihypertensive Drugs: Action of β1 Blockers
Bioavailability Enhancement: Drug Permeability Enhancement
Antihypertensive Drugs: Types of β-Blockers
Adrenergic Antagonists: ɑ and β-Receptor Blockers
Factors Influencing Drug Absorption: Pharmaceutical Parameters

